Capital Advisors Ltd’s ProKidney PROK Stock Holding History

Capital Advisors Ltd’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-384	Closed	-$1K	–	1535
2024 Q3	$1K	Hold	384	–	–	﹤0.01%	1273
2024 Q2	$1K	Hold	384	–	–	﹤0.01%	1266
2024 Q1	$1K	Buy	+384	New	+$564	﹤0.01%	1256

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Advisors Ltd's PROK Position: Q4 2024 in Review

Capital Advisors Ltd sold out of ProKidney (PROK) in Q4 2024, closing a stake of 384 shares — an estimated $1K sold.

Capital Advisors Ltd first reported a position in PROK in Q1 2024 and held it in 3 quarters. The position peaked at $1K in Q3 2024. 74 funds tracked by Wall St. Rank hold PROK as of Q4 2024.

Capital Advisors Ltd reported no remaining ProKidney position as of Q4 2024 after selling out during the quarter.
Capital Advisors Ltd sold 384 ProKidney shares in Q4 2024, an estimated $1K.
Capital Advisors Ltd first reported a position in ProKidney in Q1 2024 and held it in 3 quarters.
Capital Advisors Ltd's ProKidney position peaked at $1K in Q3 2024.
74 funds tracked by Wall St. Rank held ProKidney as of Q4 2024.

Based on Capital Advisors Ltd's 13F filing for Q4 2024, filed 4 Feb 2025.